Targeting Apoptosis in Cancer von Singh, Puneet, Lim, Bora

Volltext

Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites von El-Deiry, Wafik S., Vijayvergia, Namrata, Xiu, Joanne, Scicchitano, Angelique, Lim, Bora, Yee, Nelson S., Harvey, Harold A., Gatalica, Zoran, Reddy, Sandeep

Volltext

Update on systemic treatment for newly diagnosed inflammatory breast cancer von Chainitikun, Sudpreeda, Saleem, Sadia, Lim, Bora, Valero, Vicente, Ueno, Naoto T.

Volltext

Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy von Crespo, James, Sun, Hongxia, Wu, Jimin, Ding, Qing-Qing, Tang, Guilin, Robinson, Melissa K., Chen, Hui, Sahin, Aysegul A., Lim, Bora

Volltext

Advancing Cancer Research and Medicine with Single-Cell Genomics von Lim, Bora, Lin, Yiyun, Navin, Nicholas

Volltext

Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review von Chainitikun, Sudpreeda, Fernandez, Jose Rodrigo Espinosa, Long, James P., Iwase, Toshiaki, Kida, Kumiko, Wang, Xiaoping, Saleem, Sadia, Lim, Bora, Valero, Vicente, Ueno, Naoto T.

Volltext

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype von Harano, Kenichi, Wang, Ying, Lim, Bora, Seitz, Robert S, Morris, Stephan W, Bailey, Daniel B, Hout, David R, Skelton, Rachel L, Ring, Brian Z, Masuda, Hiroko, Rao, Arvind U K, Laere, Steven Van, Bertucci, Francois, Woodward, Wendy A, Reuben, James M, Krishnamurthy, Savitri, Ueno, Naoto T

Volltext

Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for trans... von Fernandez, Jose Rodrigo Espinosa, Eckhardt, Bedrich L., Lee, Jangsoon, Lim, Bora, Pearson, Troy, Seitz, Rob S., Hout, David R., Schweitzer, Brock L., Nielsen, Tyler J., Lawrence, O. Rayne, Wang, Ying, Rao, Arvind, Ueno, Naoto T.

Volltext

Identification of frequent somatic mutations in inflammatory breast cancer von Matsuda, Naoko, Lim, Bora, Wang, Ying, Krishnamurthy, Savitri, Woodward, Wendy, Alvarez, Ricardo H., Lucci, Anthony, Valero, Vicente, Reuben, James M., Meric-Bernstam, Funda, Ueno, Naoto T.

Volltext

Expression of Programmed Death Ligand 1 (PD-L1) in Posttreatment Primary Inflammatory Breast Cancers and Clinical Implications von He, Jing, Huo, Lei, Ma, Junsheng, Zhao, Jun, Bassett, Roland L, Sun, Xiaoping, Ueno, Naoto T, Lim, Bora, Gong, Yun

Volltext

Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer von Lee, Hee Jin, Park, In Ah, Park, So Yeon, Seo, An Na, Lim, Bora, Chai, Yun, Song, In Hye, Kim, Na Eun, Kim, Joo Young, Yu, Jong Han, Ahn, Jin-Hee, Gong, Gyungyub

Volltext

A Randomized Controlled Trial of the Korean Version of the Program for the Education and Enrichment of Relational Skills for Young Adults (PEERS®-YA-K) With Autism Spectrum Disorde... von Oh, Miae, Laugeson, Elizabeth, Kim, Joo-Hyun, Lee, Kyungah, Kim, Jeeyun, Lee, SeungHa, Lim, Bora, Cha, Seyoung, Bong, Guiyoung, Yoon, Nan-He, Bahn, Geon Ho, Yoo, Hee Jeong

Volltext

MEK and PI3K catalytic activity as predictor of the response to molecularly targeted agents in triple-negative breast cancer von Sato, Natsuki, Wakabayashi, Masayuki, Nakatsuji, Masatoshi, Kashiwagura, Haruka, Shimoji, Naohiro, Sakamoto, Shiho, Ishida, Atsuko, Lee, Jangsoon, Lim, Bora, Ueno, Naoto T., Ishihara, Hideki, Inui, Takashi

Volltext

Novel therapeutic strategies in the treatment of triple-negative breast cancer von Oualla, Karima, El-Zawahry, Heba M., Arun, Banu, Reuben, James M., Woodward, Wendy A., Gamal El-Din, Heba, Lim, Bora, Mellas, Nawfel, Ueno, Naoto T., Fouad, Tamer M.

Volltext

Clinicopathological Features of Breast Cancer with Polysomy 17 and Its Response to Neoadjuvant Chemotherapy von Sun, Hongxia, Chen, Hui, Crespo, James, Tang, Guilin, Robinson, Melissa, Lim, Bora, Şahin, Ayşegül A

Volltext

ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells von Lim, Bora, Peterson, Christine B., Davis, Alexander, Cho, Elin, Pearson, Troy, Liu, Huey, Hwang, Minha, Ueno, Naoto Tada, Lee, Jangsoon

Volltext

Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer von Ueno, Naoto T., Tahara, Rie K., Fujii, Takeo, Reuben, James M., Gao, Hui, Saigal, Babita, Lucci, Anthony, Iwase, Toshiaki, Ibrahim, Nuhad K., Damodaran, Senthil, Shen, Yu, Liu, Diane D., Hortobagyi, Gabriel N., Tripathy, Debu, Lim, Bora, Chasen, Beth A.

Volltext

Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer von Irajizad, Ehsan, Wu, Ranran, Vykoukal, Jody, Murage, Eunice, Spencer, Rachelle, Dennison, Jennifer B., Moulder, Stacy, Ravenberg, Elizabeth, Lim, Bora, Litton, Jennifer, Tripathym, Debu, Valero, Vicente, Damodaran, Senthil, Rauch, Gaiane M., Adrada, Beatriz, Candelaria, Rosalind, White, Jason B., Brewster, Abenaa, Arun, Banu, Long, James P., Do, Kim Anh, Hanash, Sam, Fahrmann, Johannes F.

Volltext

Improving the odds together: a framework for breast cancer research scientists to include patient advocates in their research von Stires, Hillary, Bado, Igor, Brown, Thelma, Carlson, Martha, Chan, Isaac S., Echeverria, Gloria V., Ewald, Andrew J., Lim, Bora, Lloyd, Carla, Maues, Julia, Oesterreich, Steffi, Riter, Robert N., Shanahan, Kelly, Welm, Alana L., Newby, Josh

Volltext

Current challenges of metastatic breast cancer von Lim, Bora, Hortobagyi, Gabriel N.

Volltext